Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acasti Pharma Inc (NASDAQ:ACST)

1.38
Delayed Data
As of 3:39pm ET
 -0.0189 / -1.35%
Today’s Change
1.20
Today|||52-Week Range
4.20
-45.88%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues725.0K478.6K240.5K28.8K
 
 
 
 
 
Cost of Goods Sold406.8K278.9K208.9K62.3K
 
 
 
 
 
Depreciation And Amortization665.7K1.7M2.1M1.8M
 
 
 
 
 
 
Operating ExpensesGross Income-347.6K-1.5M-2.0M-1.9M
 
 
 
 
 
General Expenses7.0M9.1M9.2M5.4M
 
 
 
 
 
Research And Development3.4M4.4M6.0M3.7M
 
 
 
 
 
Total Operating Expenses8.1M11.1M11.5M7.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.4M-10.6M-11.2M-7.2M
 
 
 
 
 
Extraordinary Credit0.00--7.8M1.7M
 
 
 
Extraordinary Charge0.00-484.9K---259.5K
 
 
 
Other Expenses40.2K-321.8K1.6M780.7K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.3M-11.4M-1.7M-5.0M
 
 
 
 
 
Income Taxes-370.7K-257.6K-234.9K-129.2K
 
 
 
 
 
Net Income-6.9M-11.1M-1.5M-4.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS7.3M8.4M10.6M10.7M
 
 
 
 
 
Shares To Calculate EPS Diluted7.3M8.4M10.6M10.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.90-$1.34-$0.18-$0.45
 
 
 
 
 
EPS Diluted-$0.90-$1.34-$0.18-$0.45